Heme arginate ( DrugBank: Heme arginate )

---

1 disease

ID	Disease name (Link within this page)	Number of trials
254	Porphyria	4

254. Porphyria

---

Clinical trials : 72 /  Drugs : 53 - (DrugBank : 16) / Drug target genes : 19 - Drug target pathways : 35

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT00004398 (ClinicalTrials.gov)	January 1998	18/10/1999	Phase I Study of Heme Arginate With or Without Tin Mesoporphyrin in Patients With Acute Attacks of Porphyria		Porphyria	Drug: heme arginate;Drug: tin mesoporphyrin	National Center for Research Resources (NCRR)	University of Texas	Completed	18 Years	N/A	Both	24	Phase 1	NULL
2	NCT00004397 (ClinicalTrials.gov)	January 1998	18/10/1999	Phase I Study of Tin Mesoporphyrin in Patients on Long Term Heme Therapy for Prevention of Acute Attacks of Porphyria		Porphyria	Drug: heme arginate;Drug: tin mesoporphyrin	National Center for Research Resources (NCRR)	University of Texas	Completed	18 Years	N/A	Both	20	Phase 1	NULL
3	NCT00004396 (ClinicalTrials.gov)	September 1997	18/10/1999	Studies in Porphyria III: Heme and Tin Mesoporphyrin in Acute Porphyrias		Porphyria	Drug: heme arginate;Drug: tin mesoporphyrin	National Center for Research Resources (NCRR)	University of Texas	Completed	18 Years	N/A	Both	32	Phase 2	United States
4	NCT00004789 (ClinicalTrials.gov)	July 1993	24/2/2000	Phase I/II Study of Heme Arginate and Tin Mesoporphyrin for Acute Porphyria		Porphyria	Drug: heme arginate;Drug: tin mesoporphyrin	National Center for Research Resources (NCRR)	University of Texas	Completed	18 Years	N/A	Both	59	Phase 1/Phase 2	NULL